Brian Michael Bonnell, Chief Financial Officer of ICU Medical Inc/DE (NASDAQ:ICUI), filed a Form 4 on September 1, 2026, disclosing the sale of 6,381 shares of common stock on the same date pursuant to a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Shares sold: Brian Michael Bonnell disposed of 6,381 shares of ICU Medical common stock on September 1, 2026.
- Sale price: All shares were sold at exactly $175 per share, according to the filing.
- 10b5-1 plan: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Bonnell on June 1, 2026.
- Transaction code: The transaction is coded "S" (sale) and classified as a disposition (D) in Table I of the filing.
- Remaining ownership: Following the transaction, Bonnell directly beneficially owned 56,062 shares of ICU Medical common stock.
ICU Medical CFO's September 2026 Share Disposition Details
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Brian Michael Bonnell, identified in the filing as Chief Financial Officer of ICU Medical Inc/DE, sold 6,381 shares of the company's common stock on September 1, 2026. The filing notes that the form was signed by Paula Darbyshire as Attorney-in-Fact for Brian Bonnell on the same date.
The filing discloses that "the restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026." The filing further states that "all shares sold were sold at the exact price disclosed," which is listed as $175 per share. The transaction is reported as a direct disposition in Table I, covering non-derivative securities. No derivative securities transactions are reported in Table II of this filing.
Following the reported sale, the filing indicates Bonnell directly and beneficially owned 56,062 shares of ICU Medical common stock. The box indicating the transaction was made pursuant to a Rule 10b5-1(c) plan is checked on the filing's cover page.
What Was Disclosed
ICU Medical CFO Brian Michael Bonnell reported the sale of 6,381 shares of common stock at $175 per share on September 1, 2026, under a 10b5-1 plan adopted June 1, 2026, leaving him with direct beneficial ownership of 56,062 shares.




Please wait processing your request...